logo

Clinical Trial Calendar

Share
Company Name BioLineRx Ltd.
Event Name Partial results from Phase 2a study of BL-8040 in combination with KEYTRUDA
Indication Pancreatic cancer
Outcome Date
Outcome
Result Date Jan 2018
News
http://www.biolinerx.com/default.asp?pageid=16&itemid=568
Return to Clinical Trial Calendar